Try a new search

Format these results:

Searched for:

in-biosketch:true

person:jacobi04

Total Results:

495


Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C

Zeremski, Marija; Petrovic, Lydia M; Chiriboga, Luis; Brown, Queenie B; Yee, Herman T; Kinkhabwala, Milan; Jacobson, Ira M; Dimova, Rositsa; Markatou, Marianthi; Talal, Andrew H
Chemokines, chemotactic cytokines, may promote hepatic inflammation in chronic hepatitis C virus (HCV) infection through the recruitment of lymphocytes to the liver parenchyma. We evaluated the association between inflammation and fibrosis and CXCR3-associated chemokines, interferon-gamma (IFN-gamma)-inducible protein 10 (IP-10/CXCL10), monokine induced by IFN-gamma (Mig/CXCL9), and interferon-inducible T cell alpha chemoattractant (I-TAC/CXCL11), in HCV infection. Intrahepatic mRNA expression of these chemokines was analyzed in 106 chronic HCV-infected patients by real-time PCR. The intrahepatic localization of chemokine producer cells and CXCR3(+) lymphocytes was determined in selected patients by immunohistochemistry. We found elevated intrahepatic mRNA expression of all three chemokines, most markedly CXCL10, in chronic HCV-infected patients with higher necroinflammation and fibrosis. By multivariable multivariate analysis, intrahepatic CXCL10 mRNA expression levels were significantly associated with lobular necroinflammatory grade and HCV genotype 1. In the lobular region, CXCL10-expressing and CXCL9-expressing hepatocytes predominated in areas with necroinflammation. Strong CXCL11 expression was observed in almost all portal tracts, whereas CXCL9 expression varied considerably among portal tracts in the same individual. Most intrahepatic lymphocytes express the CXCR3 receptor, and the number of CXCR3(+) lymphocytes was increased in patients with advanced necroinflammation. CONCLUSION: These findings suggest that the CXCR3-associated chemokines, particularly CXCL10, may play an important role in the development of necroinflammation and fibrosis in the liver parenchyma in chronic HCV infection
PMCID:2579317
PMID: 18798334
ISSN: 1527-3350
CID: 94083

NATURALLY OCCURRING STAT-C RESISTANCE MUTATIONS IN TREATMENT-NAME HCV INFECTED PATIENTS - AN INTERNATIONAL MULTI-CENTER STUDY [Meeting Abstract]

Kuntzen, Thomas; Timm, Joerg; Berical, Andrew; Berlin, Aaron M; Oniangue-Ndza, Cesar; Lee, Bongshin; Hecker-man, David; Carlson, Jonathan; Rosen, Hugo R; Bihl, Florian K; Cerny, Andreas; Spengler, Ulrich; Liu, Zhimin; Xing, Yanming; Modey, Margret A; Fleckenstein, Jaquelyn F; Park, Vicky M; Riely, Caroline A; Lake-Bakaar, Gerond; Daar, Eric S; Jacobson, Ira M; Gomperts, Edward D; Edlin, Brian R; Donfield, Sharyne M; Chung, Raymond T; Talal, Andrew; Mar-ion, Tony N; Birren, Bruce W; Henn, Matthew R; Allen, Todd M
ISI:000259757400263
ISSN: 0270-9139
CID: 2570032

A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS [Meeting Abstract]

McHutchison, John G; Shiffman, Mitchell L; Terrault, Norah; Manns, Michael P; Di Bisceglie, Adrian M; Jacobson, Ira M; Afdhal, Nezom H; Heathcote, EJenny; Zeuzem, Stefan; Reesink, Hendrik W; George, Shelley; Adda, Nathalie; Muir, Andrew J
ISI:000259757400266
ISSN: 0270-9139
CID: 2570042

SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY OF MK-7009, A NOVEL INHIBITOR OF THE HEPATITIS C VIRUS NS3/4A PROTEASE, IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION [Meeting Abstract]

Lawitz, Eric J; Sulkowski, Mark S; Jacobson, Ira M; Faruqui, Shaban; Kraft, Walter K; Maliakkal, Benedict; Al-Ibrahim, Mohamed; Ghalib, Reem H; Gordon, Stuart C; Kwo, Paul; Rockstroh, Juergen; Miller, Michelle; Hwang, Peggy; Gress, Jacqueline; Quirk, Erin
ISI:000259757400208
ISSN: 0270-9139
CID: 2570022

VIRAL RESPONSES IN AFRICAN-AMERICANS, LATINOS AND CAUCASIANS IN THE US PHASE 2 STUDY (PROVE1) OF TELAPREVIR WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAME GENOTYPE 1-INFECTED SUBJECTS WITH HEPATITIS C [Meeting Abstract]

Muir, Andrew J; Lawitz, Eric J; McHutchison, John G; Gordon, Stuart C; Jacobson, Ira M; Adiwijaya, Bambang S; Bengtsson, Leif; McNair, Lindsay; Rodriguez-Torres, Maribel
ISI:000259757402522
ISSN: 0270-9139
CID: 2570092

TARIBAVIRIN EXPOSURE ANALYSIS FROM A PREVIOUS PHASE 3 TRIAL CORRELATES WITH PHASE 2B WEIGHT BASED DOSING INTERIM RESULTS [Meeting Abstract]

Pockros, Paul; Jacobson, Ira M; Bacon, Bruce R; Afdhal, Nezam H; Poordad, Fred; Chun, Eric; Hammond, Janet
ISI:000259757402533
ISSN: 0270-9139
CID: 2570102

ANTIVIRAL ACTIVITY OF THE HCV NUCLEOSIDE POLYMERASE INHIBITOR R7128 IN HCV GENOTYPE 2 AND 3 PRIOR NON-RESPONDERS: INTERIM RESULTS OF R7128 1500MG BID WITH PEG-IFN AND RIBAVIRIN FOR 28 DAYS [Meeting Abstract]

Gane, Edward J; Rodriguez-Torres, Maribel; Nelson, David R; Jacobson, Ira M; McHutchison, John G; Jeffers, Lennox; Beard, Amanda; Walker, Sue; Shulman, Nancy; Symonds, William; Albanis, Efsevia; Berrey, MM
ISI:000259757402288
ISSN: 0270-9139
CID: 2570072

HCV SPRINT-1: BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN FOR TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN PREVIOUSLY UNTREATED PATIENTS [Meeting Abstract]

Kwo, Paul; Lawitz, Eric J; McCone, Jonathan; Schiff, Eugene R; Vierling, John M; Pound, David; Davis, Mitchell; Galati, Joseph S; Gordon, Stuart C; Ravendhran, Natarajan; Rossaro, Lorenzo; Anderson, Frank H; Jacobson, Ira M; Rubin, Raymond; Koury, Kenneth; Chaudhri, Eirum I; Albrecht, Janice K
ISI:000259757402293
ISSN: 0270-9139
CID: 2570082

POTENT ANTIVIRAL RESPONSE TO THE HCV NUCLEOSIDE POLYMERASE INHIBITOR R7128 FOR 28 DAYS WITH PEG-IFN AND RIBAVIRIN: SUBANALYSIS BY RACE/ETHNICITY, WEIGHT AND HCV GENOTYPE [Meeting Abstract]

Rodriguez-Torres, Maribel; Lalezari, Jay; Gane, Edward J; DeJesus, Edwin; Nelson, David R; Everson, Gregory T; Jacobson, Ira M; Reddy, KRajender; McHutchison, John G; Beard, Amanda; Walker, Sue; Symonds, William; Berrey, MM
ISI:000259757402575
ISSN: 0270-9139
CID: 2570112

GI5005 IMMUNOTHERAPY PLUS PEG-IFN/RIBAVIRIN IN GENOTYPE I CHRONIC HEPATITIS C PATIENTS COMPARED TO PEG-IFN/RIBAVIRIN ALONE IN NAIVE AND NON-RESPONDER PATIENTS; PRELIMINARY RVR AND VIRAL KINETIC ANALYSIS FROM THE GI5005-02 PHASE 2 STUDY [Meeting Abstract]

McHutchison, John G; Lawitz, Eric J; Vierling, John M; Everson, Gregory T; Jacobson, Ira M; Shiffman, Mitchell L; Boyer, Thomas D; Schiff, Eugene R; Cruickshank, Scott; Rodell, Timothy C; Apelian, David
ISI:000259757402287
ISSN: 0270-9139
CID: 2570062